Spyre Therapeutics

SYRENasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$8.115 B

$92.03 +1.97%

Close of 21 Sept 2026

Revenue

$0.00

#3637 by revenue

Earnings

-$155.2M

Loss-making

Shares outstanding

88,173,762

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#39Tg TherapeuticsTGTX$8.75B
#40Praxis Precision MedicinesPRAX$8.34B
#41Spyre TherapeuticsSYRE$8.11B
#42Ionis PharmaceuticalsIONS$7.46B
#43AlkermesALKS$7.41B

What if Spyre Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$343,345.38

Per share 3,731× higher

Bitcoin $1.72T

$19,504.71

Per share 212× higher

Nvidia $5.48T

$62,148.40

Per share 675× higher

Or at a round number

$10.0B $20.0B $50.0B $100.0B

Where these numbers come from

Share counts and financials for Spyre Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.